SELLAS Life Sciences (SLS) Share-based Compensation (2019 - 2024)
Historic Share-based Compensation for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $381000.0.
- SELLAS Life Sciences' Share-based Compensation fell 2983.43% to $381000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.7 million, marking a year-over-year decrease of 1737.64%. This contributed to the annual value of $1.6 million for FY2024, which is 2531.04% down from last year.
- According to the latest figures from Q3 2024, SELLAS Life Sciences' Share-based Compensation is $381000.0, which was down 2983.43% from $334000.0 recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences' Share-based Compensation peaked at $543000.0 during Q3 2023, and registered a low of $141000.0 during Q4 2020.
- Over the past 5 years, SELLAS Life Sciences' median Share-based Compensation value was $375000.0 (recorded in 2022), while the average stood at $347368.4.
- In the last 5 years, SELLAS Life Sciences' Share-based Compensation surged by 10425.53% in 2021 and then plummeted by 3501.95% in 2024.
- SELLAS Life Sciences' Share-based Compensation (Quarter) stood at $141000.0 in 2020, then skyrocketed by 104.26% to $288000.0 in 2021, then soared by 54.86% to $446000.0 in 2022, then grew by 11.43% to $497000.0 in 2023, then decreased by 23.34% to $381000.0 in 2024.
- Its Share-based Compensation was $381000.0 in Q3 2024, compared to $334000.0 in Q2 2024 and $476000.0 in Q1 2024.